A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAF V600 mutant advanced melanoma (INTERIM)
Titel:
A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAF V600 mutant advanced melanoma (INTERIM)
Auteur:
Dayimu, Alimu Gupta, Avinash Matin, Rubeta N. Nobes, Jenny Board, Ruth Payne, Miranda Rao, Ankit Fusi, Alberto Danson, Sarah Eccles, Bryony Carser, Judith Brown, Ciara O’Hanlon Steven, Neil Bhattacharyya, Madhumita Brown, Ewan Gonzalez, Michael Highley, Martin Pickering, Lisa Kumar, Satish Waterston, Ashita Burghel, George Demain, Leigh Baker, Eleanor Wulff, Jerome Qian, Wendi Twelves, Sophie Middleton, Mark Corrie, Pippa